
Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product candidate, Melphalan Hydrochloride for Injection for use with the Delcath Hepatic Delivery System, or Melphalan/HDS, is designed to administer high-dose chemotherapy... Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product candidate, Melphalan Hydrochloride for Injection for use with the Delcath Hepatic Delivery System, or Melphalan/HDS, is designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. Show more
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.78 | -4.79115479115 | 16.28 | 16.43 | 14.85 | 275059 | 16.00586322 | CS |
4 | -0.62 | -3.84615384615 | 16.12 | 16.97 | 14.85 | 355280 | 15.98387339 | CS |
12 | 4.28 | 38.1461675579 | 11.22 | 16.97 | 10.75 | 387542 | 13.65613751 | CS |
26 | 7.62 | 96.7005076142 | 7.88 | 16.97 | 7.83 | 379363 | 11.61710162 | CS |
52 | 11.38 | 276.213592233 | 4.12 | 16.97 | 3.7 | 313387 | 9.59550233 | CS |
156 | 9.04 | 139.938080495 | 6.46 | 16.97 | 2.25 | 349240 | 6.43487335 | CS |
260 | 11.73 | 311.140583554 | 3.77 | 25.18 | 2.25 | 253291 | 7.33370022 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales